Antepartum and postpartum serum heme oxygenase-1 levels in preeclamptic and normotensive pregnant women

In Vivo

Volumn 25, Issue 3, 2011, Pages 445-450

  Vitoratos, Nikolaos ^a   Papakonstantinou, Katerina ^a   Deliveliotou, Aikaterini ^a   Economou, Emmanuel ^a   Panoulis, Constantinos ^a   Hassiakos, Dimitrios ^a   Creatsas, George K ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Heme oxygenase 1; Mean blood pressure; Pre eclampsia

Indexed keywords

HEME OXYGENASE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GESTATION PERIOD; HUMAN; PREECLAMPSIA; PRENATAL PERIOD; PUERPERIUM;

EID: 79956347770     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sibai B, Dekker G and Kupferminc M: Pre-eclampsia. Lancet 365: 785-799, 2005. (Pubitemid 40311367)
2. Lain KY and Roberts JM: Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287: 3183-3186, 2002. (Pubitemid 34686089)
3. Sibai B: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102: 181-192, 2003.
4. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P and Thurnau G: Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild pre-eclampsia. Am J Obstet Gynecol 186: 66-71, 2002. (Pubitemid 34093742)
5. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, VanDorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G and Dombrowski M: Perinatal outcome in women with recurrent preeclampsia compared with women who develop pre-eclampsia as nulliparas. Am J Obstet Gynecol 186: 422-426, 2002. (Pubitemid 34234151)
6. Wang YP, Walsh SW, Guo JD and Zhang JY: Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy. Am J Obstet Gynecol 165: 1690-1694, 1991.
7. Gupta S, Agarwal A and Sharma RK: The role of placental oxidative stress and lipid peroxidation in pre-eclampsia. Obstet Gynecol Surv 60: 807-816, 2005. (Pubitemid 41698019)
8. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J and Romney SL: Pre-eclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with pre-eclampsia. Am J Obstet Gynecol 171: 150-157, 1994. (Pubitemid 24254434)
9. Vitoratos N, Salamalekis E, Dalamaga N, Kassanos D and Creatsas G: Defective antioxidant mechanisms via changes in serum ceruloplasmin and total iron binding capacity of serum in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 84: 63-67, 1999. (Pubitemid 29219420)
10. Hung JH: Oxidative stress and antioxidants in pre-eclampsia. J Chin Med Assoc 70: 430-432, 2007.
11. Bainbridge SA and Smith GN: HO in pregnancy. Free Radic Biol Med 38: 979-988, 2005. (Pubitemid 40386544)
12. McLaughlin BE, Lash GE, Smith GN, Marks GS, Nakatsu K, Graham CH and Brien JF: Heme oxygenase expression in selected regions of term human placenta. Exp Biol Med (Maywood) 228: 564-567, 2003. (Pubitemid 37203678)
13. Barber A, Robson SC, Myatt L, Bulmer JN and Lyall F: Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in pre-eclampsia and fetal growth restriction. FASEB J 15: 1158-1168, 2001. (Pubitemid 32436301)
14. Lash GE, McLaughlin BE, MacDonald-Goodfellow SK, Smith GN, Brien JF, Marks GS, Nakatsu K and Graham CH: Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am J Physiol Heart Circ Physiol 284: H160-167, 2003.
15. Zenclussen AC, Lim E, Knoeller S, Knackstedt M, Hertwig K, Hagen E, Klapp BF and Arck PC: Heme oxygenases in pregnancy II: HO-2 is down-regulated in human pathologic pregnancies. Am J Reprod Immunol 50: 66-76, 2003. (Pubitemid 36805766)
16. Davey DA and MacGillivray I: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158: 892-898, 1988.
17. Appleton SD, Marks GS, Nakatsu K, Brien JF, Smith GN and Graham CH: Heme oxygenase activity in placenta: direct dependence on oxygen availability. Am J Physiol Heart Circ Physiol 282: H2055-2059, 2002.
18. Appleton SD, Lash GE, Marks GS, Nakatsu K, Brien JF, Smith GN and Graham CH: Effect of glucose and oxygen deprivation on heme oxygenase expression in human chorionic villi expiants and immortalized trophoblast cells. Am J Physiol Regul Integr Comp Physiol 285: R1453-1460, 2003.
19. Eide IP, Isaksen CV, Salvesen KA, Langaas M, Schønberg SA and Austgulen R: Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Acta Obstet Gynecol Scand 87: 272-279, 2008. (Pubitemid 351317474)
20. Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM and Perkins AV: Increased biological oxidation and reduced antioxidant enzyme activity in pre-eclamptic placentae. Placenta. 26: 53-58, 2005. (Pubitemid 40123676)
21. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI and Poston L: A longitudinal study of biochemical variables in women at risk of pre-eclampsia. Am J Obstet Gynecol 187: 127-136, 2002. (Pubitemid 34800311)
22. Jauniaux E, Poston L and Burton GJ: Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12: 747-755, 2006. (Pubitemid 44605512)
23. Lyall F and Belfort M: Ed Pre-eclampsia etiology and clinical practice. Cambridge, University Press, New York, p. 110, 2007.
24. Hung JH: Oxidative stress and antioxidants in pre-eclampsia. J Chin Med Assoc 70: 430-432, 2007.
25. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN and Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235(4792): 1043-1046, 1987. (Pubitemid 17049750)
26. Zusterzeel PL, Steegers-Theunissen RP, Harren FJ, Stekkinger E, Kateman H, Timmerman BH, Berkelmans R, Nieuwenhuizen A, Peters WH, Raijmakers MT and Steegers EA: Ethene and other biomarkers of oxidative stress in hypertensive disorders of pregnancy. Hypertens Pregnancy 27: 39-49, 2002. (Pubitemid 34437744)
27. Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C and Bergman H: Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54: 1297-1304, 2000.
28. Entman SS, Kambam JR, Bradley CA and Cousar JB: Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia. Am J Obstet Gynecol 156: 1169-1173, 1987. (Pubitemid 17075469)
29. Cikot RJ, Steegers-Theunissen RP, Thomas CM, de Boo TM, Merkus HM and Steegers EA: Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 85: 49-58, 2001. (Pubitemid 32156580)
30. Callaway LK, Lawlor DA and McIntyre HD: Hypertensive disorders of pregnancy and long-term prognosis. Am J Obstet Gynecol 199: e20; author reply e20-21, 2008.
31. Bellamy L, Casas JP, Hingorani AD and Williams DJ: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335(7627): 974, 2007.
32. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I et al: Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6: 391-409, 2000.